
Jul 3, 2024, 02:35
Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X:
“Absolutely abscopal responses …. in myeloma??
Fascinating small Ph2 trial in The Lancet Haematology by Khan Sagar Lonial et al:
Pembro q3wk + 1 Fx RT to EMD sites… 7/25 responders, inc. 2 CRs. Better than I might’ve guessed for pembro monoTx in multiple myeloma.”
Read further.
Source: Rahul Banerjee/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 11:36
Feb 21, 2025, 11:29
Feb 21, 2025, 10:45